Pharmacokinetic and bioavailability studies of α-viniferin after intravenous and oral administration to rats

J Pharm Biomed Anal. 2020 Sep 5:188:113376. doi: 10.1016/j.jpba.2020.113376. Epub 2020 May 25.

Abstract

Alpha-viniferin is a trimer of resveratrol and has various pharmacological activities including anti-Alzheimer's disease, anti-tuberculosis, anti-tumor, anti-inflammatory and anti-diabetic. To investigate the pharmacokinetic characteristics and absolute bioavailability of α-viniferin in rats, using naringenin as an internal standard (IS), a rapid HPLC-MS/MS method of 5 min complete run time was developed. The chromatographic separation of α-viniferin and naringenin were accomplished with Waters XBridge™ C18 column (2.1 mm × 100 mm, 3.5 μm) and the mobile phase were acetonitrile and 0.1 % formic acid at a flow rate of 0.3 mL/min. Plasma samples were pretreated by ethyl acetate. The negative ion mode with electrospray ionization (ESI) source was used for detecting the sample. Oral bioavailability of α-viniferin was 4.2 %. This study will be beneficial in better understanding the pharmacological properties and the further development of α-viniferin.

Keywords: HP; LC–MS/MS; bioavailability; pharmacokinetics; α-viniferin.

MeSH terms

  • Administration, Intravenous
  • Administration, Oral
  • Animals
  • Benzofurans
  • Biological Availability
  • Chromatography, High Pressure Liquid
  • Rats
  • Reproducibility of Results
  • Spectrometry, Mass, Electrospray Ionization*
  • Tandem Mass Spectrometry*

Substances

  • Benzofurans
  • alpha-viniferin